Hepatic lipase: friend or foe and under what circumstances?
Hepatic lipase (HL) plays a role in the metabolism of chylomicron and very low-density lipoprotein remnants, low-density lipoproteins (LDL), and high-density lipoproteins (HDL), which are all implicated in atherosclerosis. Considering the effects of HL on these lipoproteins, it appears that HL has pro- as well as antiatherogenic potential. In line with clinical observations, most effects of HL on lipoprotein metabolism during hypertriglyceridemia may be interpreted as promoting atherosclerosis (formation of small, dense LDL, lowering of HDL levels), whereas most effects during hypercholesterolemia seem to be potentially antiatherogenic (stimulation of reverse cholesterol transport, clearing of intermediate-density lipoprotein). The potential modulation of pro- or antiatherogenics effect of HL by other factors, such as LDL receptor, cholesterol ester transfer protein, lipoprotein lipase, and ATP-binding cassette A-1 activity, is discussed.
Department of Clinical Chemistry (Room 175), ErasmusMC, Postbus 2040, 3000 CA Rotterdam, Netherlands. H.Jansen@ErasmusMC.nl
Hans
H
Jansen
D001161:Arteriosclerosis / Q000378:metabolism / Q000503:physiopathology*; D002784:Cholesterol / Q000378:metabolism*; D006801:Humans; D008049:Lipase / Q000378:metabolism*; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000378:metabolism*
C504173:LIPC protein, human; D008074:Lipoproteins; D002784:Cholesterol; D008049:Lipase